Cargando…

Paclitaxel increases axonal localization and vesicular trafficking of Na(v)1.7

The microtubule-stabilizing chemotherapy drug paclitaxel (PTX) causes dose-limiting chemotherapy-induced peripheral neuropathy (CIPN), which is often accompanied by pain. Among the multifaceted effects of PTX is an increased expression of sodium channel Na(v)1.7 in rat and human sensory neurons, enh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akin, Elizabeth J, Alsaloum, Matthew, Higerd, Grant P, Liu, Shujun, Zhao, Peng, Dib-Hajj, Fadia B, Waxman, Stephen G, Dib-Hajj, Sulayman D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320304/ https://www.ncbi.nlm.nih.gov/pubmed/33734317 http://dx.doi.org/10.1093/brain/awab113

Ejemplares similares

Paclitaxel effects on axonal localization and vesicular trafficking of Na(V)1.8
por: Baker, Christopher A., et al.
Publicado: (2023)

Conserved but not critical: Trafficking and function of Na(V)1.7 are independent of highly conserved polybasic motifs
por: Tyagi, Sidharth, et al.
Publicado: (2023)

The fates of internalized Na(V)1.7 channels in sensory neurons: Retrograde cotransport with other ion channels, axon-specific recycling, and degradation
por: Higerd-Rusli, Grant P., et al.
Publicado: (2022)

Building sensory axons: Delivery and distribution of Na(V)1.7 channels and effects of inflammatory mediators
por: Akin, Elizabeth J., et al.
Publicado: (2019)

Inflammation differentially controls transport of depolarizing Nav versus hyperpolarizing Kv channels to drive rat nociceptor activity
por: Higerd-Rusli, Grant P., et al.
Publicado: (2023)

Lacosamide Inhibition of Na(V)1.7 Channels Depends on its Interaction With the Voltage Sensor Domain and the Channel Pore
por: Labau, Julie I. R., et al.
Publicado: (2021)

Preferential Targeting of Na(v)1.6 Voltage-Gated Na(+) Channels to the Axon Initial Segment during Development
por: Akin, Elizabeth J., et al.
Publicado: (2015)

Effects of ranolazine on wild-type and mutant hNa(v)1.7 channels and on DRG neuron excitability
por: Estacion, Mark, et al.
Publicado: (2010)

Contributions of Na(V)1.8 and Na(V)1.9 to excitability in human induced pluripotent stem-cell derived somatosensory neurons
por: Alsaloum, Matthew, et al.
Publicado: (2021)

Mutation I136V alters electrophysiological properties of the Na(V)1.7 channel in a family with onset of erythromelalgia in the second decade
por: Cheng, Xiaoyang, et al.
Publicado: (2008)

Conditional knockout of Na(V)1.6 in adult mice ameliorates neuropathic pain
por: Chen, Lubin, et al.
Publicado: (2018)

Na(v)1.7 is the predominant sodium channel in rodent olfactory sensory neurons
por: Ahn, Hye-Sook, et al.
Publicado: (2011)

A novel gain-of-function Na(v)1.7 mutation in a carbamazepine-responsive patient with adult-onset painful peripheral neuropathy
por: Adi, Talia, et al.
Publicado: (2018)

Atypical changes in DRG neuron excitability and complex pain phenotype associated with a Na(v)1.7 mutation that massively hyperpolarizes activation
por: Huang, Jianying, et al.
Publicado: (2018)

Mutations at opposite ends of the DIII/S4-S5 linker of sodium channel Na(V)1.7 produce distinct pain disorders
por: Cheng, Xiaoyang, et al.
Publicado: (2010)

Kv7-specific activators hyperpolarize resting membrane potential and modulate human iPSC-derived sensory neuron excitability
por: Estacion, Mark, et al.
Publicado: (2023)

KCNQ variants and pain modulation: a missense variant in Kv7.3 contributes to pain resilience
por: Yuan, Jun-Hui, et al.
Publicado: (2021)

Expression of Nav1.7 in DRG neurons extends from peripheral terminals in the skin to central preterminal branches and terminals in the dorsal horn
por: Black, Joel A, et al.
Publicado: (2012)

Paroxysmal extreme pain disorder M1627K mutation in human Na(v)1.7 renders DRG neurons hyperexcitable
por: Dib-Hajj, Sulayman D, et al.
Publicado: (2008)

Multiple myosin motors interact with sodium/potassium-ATPase alpha 1 subunits
por: Dash, Bhagirathi, et al.
Publicado: (2018)

A Novel Gain-of-Function Nav1.9 Mutation in a Child With Episodic Pain
por: Huang, Jianying, et al.
Publicado: (2019)

Temperature dependence of erythromelalgia mutation L858F in sodium channel Nav1.7
por: Han, Chongyang, et al.
Publicado: (2007)

Nonmuscle myosin II isoforms interact with sodium channel alpha subunits
por: Dash, Bhagirathi, et al.
Publicado: (2018)

Brain activity associated with pain in inherited erythromelalgia: stimulus-free pain engages brain areas involved in valuation and learning
por: Geha, Paul, et al.
Publicado: (2018)

Intra- and interfamily phenotypic diversity in pain syndromes associated with a gain-of-function variant of Na(V)1.7
por: Estacion, Mark, et al.
Publicado: (2011)

Nav1.7 is phosphorylated by Fyn tyrosine kinase which modulates channel expression and gating in a cell type-dependent manner
por: Li, Yangyang, et al.
Publicado: (2018)

Na(v) 1.7 gain-of-function mutation I228M triggers age-dependent nociceptive insensitivity and C-LTMR dysregulation
por: Wimalasena, Nivanthika K., et al.
Publicado: (2023)

Oral Administration of PF-01247324, a Subtype-Selective Nav1.8 Blocker, Reverses Cerebellar Deficits in a Mouse Model of Multiple Sclerosis
por: Shields, Shannon D., et al.
Publicado: (2015)

Network topology of NaV1.7 mutations in sodium channel-related painful disorders
por: Kapetis, Dimos, et al.
Publicado: (2017)

Fibroblast growth factor homologous factor 2 (FGF-13) associates with Nav1.7 in DRG neurons and alters its current properties in an isoform-dependent manner
por: Effraim, Philip R., et al.
Publicado: (2019)

Rat Na(V)1.7 loss-of-function genetic model: Deficient nociceptive and neuropathic pain behavior with retained olfactory function and intra-epidermal nerve fibers
por: Grubinska, B, et al.
Publicado: (2019)

Non-psychotropic phytocannabinoid interactions with voltage-gated sodium channels: An update on cannabidiol and cannabigerol
por: Ghovanloo, Mohammad-Reza, et al.
Publicado: (2022)

Differential effect of lacosamide on Na(v)1.7 variants from responsive and non-responsive patients with small fibre neuropathy
por: Labau, Julie I R, et al.
Publicado: (2020)

The AMPK Activator A769662 Blocks Voltage-Gated Sodium Channels: Discovery of a Novel Pharmacophore with Potential Utility for Analgesic Development
por: Asiedu, Marina N., et al.
Publicado: (2017)

Genomic analysis of 21 patients with corneal neuralgia after refractive surgery
por: Yuan, Jun-Hui, et al.
Publicado: (2020)

Familial trigeminal neuralgia – a systematic clinical study with a genomic screen of the neuronal electrogenisome
por: Di Stefano, Giulia, et al.
Publicado: (2020)

High-throughput combined voltage-clamp/current-clamp analysis of freshly isolated neurons
por: Ghovanloo, Mohammad-Reza, et al.
Publicado: (2023)

Lessons learned in translating pain knowledge into practice
por: Becker, Juliane, et al.
Publicado: (2023)

A gain-of-function sodium channel β2-subunit mutation in painful diabetic neuropathy
por: Alsaloum, Matthew, et al.
Publicado: (2019)

Therapeutic potential of Pak1 inhibition for pain associated with cutaneous burn injury
por: Guo, Yiqun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qt87lkbp79p3okrmd2d2d7vq3t